MT Newswires
European Equities Traded in the US as American Depositary Receipts Slide in Thursday Trading
âž–
AI Sentiment
Neutral
4/10
- Home
- SNN
as of 03-09-2026 10:49am EST
$33.63
$0.64
-1.87%
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
| Founded: | 1856 | Country: | United Kingdom |
| Employees: | N/A | City: | N/A |
| Market Cap: | 14.3B | IPO Year: | N/A |
| Target Price: | $36.25 | AVG Volume (30 days): | 836.3K |
| Analyst Decision: | Hold | Number of Analysts: | 3 |
| Dividend Yield: | Dividend Payout Frequency: | N/A | |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | $23.91 - $38.79 | Next Earning Date: | N/A |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | 7.19% | Revenue Growth (next year): | 5.36% |
| P/E Ratio: | 64.97 | Index: | N/A |
| Free Cash Flow: | N/A | FCF Growth: | +40.59% |
Latest Smith & Nephew SNATS Inc. News
SNN Breaking Stock News: Dive into SNN Ticker-Specific Updates for Smart Investing
MT Newswires
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
📊
AI Sentiment
Positive
7/10
GuruFocus.com
Smith & Nephew PLC (SNN) Full Year 2025 Earnings Call Highlights: Strong Revenue Growth and ...
📊
AI Sentiment
Positive
7/10
GlobeNewswire
Smith+Nephew to showcase advanced Orthopaedic Handheld Robotics, Reconstruction and Trauma technologies during AAOS 2026
📈
AI Sentiment
Highly Positive
9/10
MT Newswires
European Equities Traded in US as ADRs Tumble in Tuesday Trading
📉
AI Sentiment
Negative
3/10
GlobeNewswire
Smith+Nephew to feature leading rotator cuff repair portfolio including new Tendon Seamâ„¢ Repair System and REGENETENâ—Š Bioinductive Implant at AAOS 2026
📈
AI Sentiment
Highly Positive
9/10
MT Newswires
Smith & Nephew Q4 Adjusted Earnings, Revenue Increase; 2026 Revenue Growth Outlook Issued
📈
AI Sentiment
Highly Positive
8/10
Compare SNN vs Leading Stocks
See how SNN stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "SNN Smith & Nephew SNATS Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.